SL
SVB Leerink Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
1
Cytokinetics
CYTK
$5.95B
|
RR
Roanna Ruiz
| $49.75 | $58 |
17%
upside
| Outperform | 2 years ago |
|
2
Design Therapeutics
DSGN
$348M
|
JS
Joseph Schwartz
| $6.11 | $6 |
2%
downside
| Market Perform | 2 years ago |
|
3
Nuvalent
NUVL
$5.74B
|
CL
Christopher Liu
| $79.67 | $42 |
47%
downside
| Market Perform | 2 years ago |
|
4
IDEAYA Biosciences
IDYA
$2.26B
|
CL
Christopher Liu
| $25.83 | $33 |
28%
upside
| Outperform | 2 years ago |
|
5
Exelixis
EXEL
$10.1B
|
CL
Christopher Liu
| $37.38 | $18 |
52%
downside
| Market Perform | 2 years ago |
|
6
NovoCure
NVCR
$1.34B
|
JC
Jonathan Chang
| $11.98 | $51 |
326%
upside
| Outperform | 2 years ago |
|
|
BLTE
7
Belite Bio
BLTE
$2.14B
|
MG
Marc Goodman
| $65.14 | $25 |
62%
downside
| Outperform | 2 years ago |
|
8
CryoPort
CYRX
$443M
|
PS
Puneet Souda
| $8.85 | $10 |
13%
upside
| Market Perform | 2 years ago |
|
9
Bristol-Myers Squibb
BMY
$95B
|
DR
David Risinger
| $46.69 | $66 |
41%
upside
| Market Perform | 2 years ago |
|
10
Thermo Fisher Scientific
TMO
$185B
|
PS
Puneet Souda
| $489.49 | $630 |
29%
upside
| Outperform | 2 years ago |
|
11
Arrowhead Research
ARWR
$3.87B
|
MF
Mani Foroohar
| $28 | $40 |
43%
upside
| Market Perform | 2 years ago |
|
12
Waters Corp
WAT
$17.8B
|
PS
Puneet Souda
| $299.69 | $300 |
0%
upside
| Market Perform | 2 years ago |
|
13
Danaher
DHR
$143B
|
PS
Puneet Souda
| $199.03 | $300 |
51%
upside
| Outperform | 2 years ago |
|
14
Prothena Corp
PRTA
$442M
|
RL
Rudy Li
| $8.21 | $80 |
874%
upside
| Outperform | 2 years ago |
|
15
Corcept Therapeutics
CORT
$7.31B
|
RR
Roanna Ruiz
| $69.37 | $25 |
64%
downside
| Market Perform | 2 years ago |
|
16
Arcellx
ACLX
$4B
|
DG
Daina Graybosch
| $72.16 | $39 |
46%
downside
| Outperform | 2 years ago |
|
17
Regeneron Pharmaceuticals
REGN
$60.1B
|
DR
David Risinger
| $567.22 | $976 |
72%
upside
| Outperform | 2 years ago |
|
18
Incyte
INCY
$16.7B
|
AB
Andrew Berens
| $85.44 | $60 |
30%
downside
| Underperform | 2 years ago |
|
|
CNTA
19
Centessa Pharmaceuticals
CNTA
$2.12B
|
DR
David Risinger
| $15.79 | $6 |
62%
downside
| Outperform | 2 years ago |
|
20
PTC Therapeutics
PTCT
$4.61B
|
JS
Joseph Schwartz
| $58.01 | $48 |
17%
downside
| Market Perform | 2 years ago |
|
21
Halozyme
HALO
$8.59B
|
DR
David Risinger
| $73.40 | $42 |
43%
downside
| Market Perform | 2 years ago |
|
22
argenx
ARGX
$44.9B
|
TS
Thomas Smith
| $733.66 | $435 |
41%
downside
| Outperform | 2 years ago |
|
23
Disc Medicine
IRON
$2.09B
|
TS
Thomas Smith
| $60.19 | $36 |
40%
downside
| Outperform | 2 years ago |
|
24
Nektar Therapeutics
NKTR
$684M
|
DG
Daina Graybosch
| $35.98 | $45 |
25%
upside
| Market Perform | 2 years ago |
|
25
Moderna
MRNA
$9.45B
|
MF
Mani Foroohar
| $24.28 | $93 |
283%
upside
| Underperform | 2 years ago |
|